Zilovertamab vedotin
Disitamab vedotin
Cofetuzumab pelidotin
Patritumab deruxtecan
Farletuzumab ecteribulin
Sofituzumab vedotin
Labetuzumab govitecan
Cantuzumab ravtansine
Cantuzumab mertansine
Tusamitamab ravtansine
Trastuzumab duocarmazine
Azintuxizumab vedotin
Loncastuximab tesirine
Trastuzumab emtansine
Trastuzumab emtansine (solution)
Brentuximab vedotin (solution)
Enfortumab vedotin-ejfv
Enfortumab vedotin-ejfv (solution)
Ifinatamab deruxtecan
Belantamab mafodotin